Ligand validation:8PT5

ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8PT5_ANP_A_401	85%	40%	0.101	0.968	1.16	1.19	4	3	0	0	100%	1
4FMQ_ANP_A_401	96%	5%	0.069	0.976	2.56	2.63	7	5	1	0	100%	1
8PT0_ANP_A_401	92%	23%	0.079	0.969	1.42	1.72	6	4	0	0	100%	1
8PT1_ANP_A_401	91%	30%	0.079	0.967	1.24	1.55	4	3	0	0	100%	1
8PSR_ANP_A_401	86%	38%	0.111	0.981	1.13	1.31	2	4	0	0	100%	1
4NIF_ANP_E_401	83%	14%	0.127	0.988	2.44	1.46	7	5	1	0	100%	1
8PS7_ANP_A_704	100%	43%	0.023	0.994	1.15	1.05	4	2	0	0	100%	1
9AVR_ANP_A_501	100%	36%	0.034	0.991	1.05	1.46	2	5	2	0	100%	1
4BRA_ANP_A_1394	100%	12%	0.037	0.993	2.3	1.8	10	6	3	0	100%	1
4DFX_ANP_E_402	100%	32%	0.036	0.989	1.35	1.35	4	2	1	0	100%	1
4BRD_ANP_B_1396	100%	16%	0.041	0.994	1.66	2.04	4	10	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.